跳至主要内容
临床试验/IRCT201203051556N39
IRCT201203051556N39已完成2 期

Effect of Saffron Versus Memantine in patients with severe Alzheimer's disease: randomized double-blind placebo-controlled study

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60 years 至 80 years(—)
性别
All

入选标准

  • Inclusion Criteria: A diagnosis of Alzheimer’s disease according to the criteria of National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer’s Disease and Related Disorders Association (NINCDS/ADRDA); Presence of severe dementia: MMSE8-14].

排除标准

  • Concomitant diseases such as hypertension, congestive heart failure, non-insulin dependent diabetes mellitus and hypothyroidism; Patients with evidence of other neurodegenerative disorders; Any cardiovascular disease likely to prevent completion of the study; Clinically significant psychiatric diseases; Urinary outflow obstruction; Active peptic ulcer; Any history of epilepsy; Significant drug or alcohol misuse; Drugs with anticholinergic effects or cholinomimetic effects

研究者

相似试验